A Report on Emerging Evidence and Implications of COVID-19 Related Tinnitus: Preliminary Survey Results

Abstract

This research explores the COVID-19 vaccination connection to tinnitus, considering its onset and exacerbation post vaccination. A survey of 417 respondents (mean age 63.2 years), mainly European American/White, studied COVID-19, vaccines, and tinnitus. Preliminary results showed those aged 46 to 65 had higher tinnitus rates. Pfizer-BioNTech was common (initial first dose 54%), and 86.7% hadn't had COVID-19 infection prior to vaccination. Before vaccination, 45.8% reported no tinnitus, while 32.4% had persistent tinnitus symptoms. Tinnitus symptoms worsened post-vaccination for most, with varying durations. The onset of new tinnitus post vaccination occurred particularly after the second dose. Psychological distress is linked to tinnitus development, affecting the quality of life. A participant's struggle underscores the need for support. The conclusion emphasizes vigilance, intervention, and collaboration to address tinnitus and its impact. Ongoing research is essential for understanding COVID-19-related tinnitus